The global macrolide drugs market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of respiratory tract infections and other bacterial infections in developing countries, which is driving the demand for macrolide drugs.
1Membered Ring Agents accounted for the largest share in the global macrolide drugs market in 2018 and are expected to continue their dominance throughout the forecast period. 1Membered Ring Agents are used as first-line treatment for various bacterial infections such as pneumonia, bronchitis, sinusitis, and ear infection. They are also used as second-line treatment for tuberculosis (TB) patients who have failed on first-line therapy with rifampicin or pyrazinamide. Ketolides accounted for a small share in 2018 but are expected to grow at a CAGR of 6% during 2020-2030 due to their efficacy against TB strains resistant against rifampicin or pyrazinamide therapy.
- The increasing prevalence of respiratory tract infections and the emergence of drug-resistant bacteria are driving the growth of macrolide drugs market.
- The increasing number of patients with chronic obstructive pulmonary disease (COPD) is also driving the growth of macrolide drugs market.
- The growing awareness about the benefits offered by macrolide drugs is also driving the growth of this market.
- Increasing government initiatives to promote healthy living and prevent diseases are expected to drive this market in future.
- Increasing geriatric population is also expected to drive this market in future.
Industry Growth Insights published a new data on “Macrolide Drugs Market”. The research report is titled “Macrolide Drugs Market research by Types (14-Membered Ring Agents, 15-Membered Ring Agents, 16-Membered Ring Agents, Ketolides), By Applications (Hospitals, Clinics, Hospitalshospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Players/Companies Abbott Laboratories, Akorn, Eli Lilly & Co., Fresenius Kabi, Gland Pharmm, Sirolimus, Neo QuÃmica, Tacorolimus, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Macrolide Drugs Market Research Report
By Type
14-Membered Ring Agents, 15-Membered Ring Agents, 16-Membered Ring Agents, Ketolides
By Application
Hospitals, Clinics, Hospitalshospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Abbott Laboratories, Akorn, Eli Lilly & Co., Fresenius Kabi, Gland Pharmm, Sirolimus, Neo QuÃmica, Tacorolimus, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Macrolide Drugs Market Report Segments:
The global Macrolide Drugs market is segmented on the basis of:
Types
14-Membered Ring Agents, 15-Membered Ring Agents, 16-Membered Ring Agents, Ketolides
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Hospitalshospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Akorn
- Eli Lilly & Co.
- Fresenius Kabi
- Gland Pharmm
- Sirolimus
- Neo QuÃmica
- Tacorolimus
- Macrolide Pharmaceuticals
- Mylan
- Pfizer
- Sanofi
- Merck & Co.
- Sandoz International
- Teva Pharmaceutical Industries
- WOCKHARDT
Highlights of The Macrolide Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 14-Membered Ring Agents
- 15-Membered Ring Agents
- 16-Membered Ring Agents
- Ketolides
- By Application:
- Hospitals
- Clinics
- Hospitalshospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Macrolide Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Macrolide drugs are a type of antibiotic that work by stopping the growth of bacteria. They are often used to treat infections, such as bronchitis, pneumonia, and urinary tract infections.
Some of the key players operating in the macrolide drugs market are Abbott Laboratories, Akorn, Eli Lilly & Co., Fresenius Kabi, Gland Pharmm, Sirolimus, Neo QuƒÂmica, Tacorolimus, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT.
The macrolide drugs market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Macrolide Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Macrolide Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Macrolide Drugs Market - Supply Chain
4.5. Global Macrolide Drugs Market Forecast
4.5.1. Macrolide Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Macrolide Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Macrolide Drugs Market Absolute $ Opportunity
5. Global Macrolide Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Macrolide Drugs Market Size and Volume Forecast by Type
5.3.1. 14-Membered Ring Agents
5.3.2. 15-Membered Ring Agents
5.3.3. 16-Membered Ring Agents
5.3.4. Ketolides
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Macrolide Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Macrolide Drugs Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Hospitalshospital Pharmacies
6.3.4. Retail Pharmacies
6.3.5. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Macrolide Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Macrolide Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Macrolide Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Macrolide Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Macrolide Drugs Demand Share Forecast, 2019-2026
9. North America Macrolide Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Macrolide Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Macrolide Drugs Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Hospitalshospital Pharmacies
9.4.4. Retail Pharmacies
9.4.5. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Macrolide Drugs Market Size and Volume Forecast by Type
9.7.1. 14-Membered Ring Agents
9.7.2. 15-Membered Ring Agents
9.7.3. 16-Membered Ring Agents
9.7.4. Ketolides
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Macrolide Drugs Demand Share Forecast, 2019-2026
10. Latin America Macrolide Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Macrolide Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Macrolide Drugs Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Hospitalshospital Pharmacies
10.4.4. Retail Pharmacies
10.4.5. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Macrolide Drugs Market Size and Volume Forecast by Type
10.7.1. 14-Membered Ring Agents
10.7.2. 15-Membered Ring Agents
10.7.3. 16-Membered Ring Agents
10.7.4. Ketolides
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Macrolide Drugs Demand Share Forecast, 2019-2026
11. Europe Macrolide Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Macrolide Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Macrolide Drugs Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Hospitalshospital Pharmacies
11.4.4. Retail Pharmacies
11.4.5. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Macrolide Drugs Market Size and Volume Forecast by Type
11.7.1. 14-Membered Ring Agents
11.7.2. 15-Membered Ring Agents
11.7.3. 16-Membered Ring Agents
11.7.4. Ketolides
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Macrolide Drugs Demand Share, 2019-2026
12. Asia Pacific Macrolide Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Macrolide Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Macrolide Drugs Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Hospitalshospital Pharmacies
12.4.4. Retail Pharmacies
12.4.5. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Macrolide Drugs Market Size and Volume Forecast by Type
12.7.1. 14-Membered Ring Agents
12.7.2. 15-Membered Ring Agents
12.7.3. 16-Membered Ring Agents
12.7.4. Ketolides
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Macrolide Drugs Demand Share, 2019-2026
13. Middle East & Africa Macrolide Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Macrolide Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Macrolide Drugs Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Hospitalshospital Pharmacies
13.4.4. Retail Pharmacies
13.4.5. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Macrolide Drugs Market Size and Volume Forecast by Type
13.7.1. 14-Membered Ring Agents
13.7.2. 15-Membered Ring Agents
13.7.3. 16-Membered Ring Agents
13.7.4. Ketolides
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Macrolide Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Macrolide Drugs Market: Market Share Analysis
14.2. Macrolide Drugs Distributors and Customers
14.3. Macrolide Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Akorn
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eli Lilly & Co.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius Kabi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gland Pharmm
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sirolimus
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Neo Química
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Tacorolimus
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Macrolide Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Mylan
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Pfizer
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Sanofi
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Merck & Co.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Sandoz International
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Teva Pharmaceutical Industries
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. WOCKHARDT
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
